Clinical Trial Update: HFSRT With Concurrent TMZ for Large BMs [Phase 3]

View source ↗

Summary

Phase 3 trial update on hypofractionated stereotactic radiotherapy (HFSRT) with concurrent temozolomide (TMZ) for large brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• HFSRT (hypofractionated stereotactic radiotherapy)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Brain Metastases, Chemotherapy | Phase 3 | Status: UNKNOWN